Home Table of Contents

§ 100603. Publication Requirements.

17 CA ADC § 100603Barclays Official California Code of Regulations

Barclays California Code of Regulations
Title 17. Public Health
Division 4. California Institute for Regenerative Medicine
Chapter 6. Intellectual Property and Revenue Sharing Requirements for Non-Profit and for-Profit Grantees
17 CCR § 100603
§ 100603. Publication Requirements.
(a) A Grantee must provide for public access to any publication of a CIRM-Funded Invention or CIRM-Funded Technology, as provided in this section.
(b) For any manuscript that is peer-reviewed and accepted for publication in a scientific journal, the Grantee must ensure that an electronic version of the final peer-reviewed manuscript is submitted to PubMed Central or to CIRM to be made publicly available no later than 12 months after the official date of publication. The Grantee shall make reasonable efforts to comply with this requirement through submission to PubMed Central, including notifying CIRM of the PubMed Central identification number. If the Grantee is unable to submit the manuscript to PubMed Central, the Grantee may comply by providing the manuscript to CIRM, no later than 12 months after the official date of publication. In lieu of the final peer-reviewed manuscript, the Grantee may submit the final published article.
(c) For publications other than those described in subsection (b), including meeting abstracts, the Grantee must comply by providing the manuscript to CIRM no later than 12 months after the official date of publication.
(d) Grantees are responsible for ensuring that any publishing or copyright agreements concerning submitted articles fully comply with this Regulation.
(e) Within 60 calendar days of the publication, Grantees shall notify CIRM of the Grant Number, Grantee Institution, Principal Investigator and the PubMed Central identification number for the manuscript. In addition, Grantees shall provide CIRM with a short paragraph, written for the general public, describing both the importance of the discovery that is the subject of the publication and the approach or methodology employed. Neither the publication abstract nor the statement of public benefit submitted as part of the application satisfy this requirement.
(f) A Grantee must ensure that the final abstract or manuscript includes the URL of a website where a Materials Transfer Agreement (or similar document) can be accessed to facilitate requests for Publication-related Biomedical Materials.
(g) Any written or oral publication reporting a CIRM-Funded Invention or CIRM-Funded Technology must acknowledge CIRM funding. An example of an acknowledgement is:
“This research was made possible by a grant from the California Institute for Regenerative Medicine (Grant Number __________). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of CIRM or any other agency of the State of California.”

Credits

Note: Authority cited: Article XXXV, California Constitution; and Section 125290.40(j), Health and Safety Code. Reference: Section 125290.30, Health and Safety Code.
History
1. New section filed 12-17-2009; operative 12-17-2009 pursuant to Government Code section 11343.4 (Register 2009, No. 51). For prior history, see Register 2007, No. 26.
2. Repealer and new subsections (a) and (b), new subsections (c)-(e) and subsection relettering filed 3-21-2013; operative 7-1-2013 (Register 2013, No. 12).
This database is current through 4/26/24 Register 2024, No. 17.
Cal. Admin. Code tit. 17, § 100603, 17 CA ADC § 100603
End of Document